
AI optimizes antibodies to tackle evolving SARS-CoV-2 variants
Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have successfully used an AI-driven platform to preemptively optimize an antibody to neutralize a broad diversity of SARS-CoV-2 variants.This post was originally […]